The Prostacyclin Analogue Treprostinil Blocks NFκB Nuclear Translocation in Human Alveolar Macrophages
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (36) , 33344-33348
- https://doi.org/10.1074/jbc.m203567200
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Chemokine RANTES in Severe Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Increased Levels of Prostaglandin D2 Suggest Macrophage Activation in Patients With Primary Pulmonary HypertensionChest, 2001
- Nitric Oxide Blocks Nuclear Factor- κ B Activation in Alveolar MacrophagesAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- Chemokine Macrophage Inflammatory Protein-1α mRNA Expression in Lung Biopsy Specimens of Primary Pulmonary HypertensionChest, 1998
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol InfusionJournal of the American College of Cardiology, 1997
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertensionEuropean Respiratory Journal, 1995
- Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.American Journal of Respiratory and Critical Care Medicine, 1995